More Problems with the COVID Vax, By Brian Simpson

The Focal Points article (published March 13, 2026, by Nicolas Hulscher, MPH) is titled "BREAKING STUDY: COVID-19 "Vaccination" Linked to 6,800% Higher Odds of Debilitating Autoimmune Muscle Disease". It promotes a new paper titled "Association Between COVID-19 Vaccination and Polymyalgia Rheumatica: A Review and Case Series Report," co-authored by Hulscher alongside Dr. Peter A. McCullough and others affiliated with the McCullough Foundation (including Dr. James Thorp, Dr. Steven Hatfill, Dr. Drew Pinsky, and more). The piece frames the findings as a "massive safety signal" overlooked by regulators, emphasising the debilitating nature of polymyalgia rheumatica (PMR) — an inflammatory autoimmune disorder causing severe pain, stiffness (especially mornings), fatigue, and often requiring long-term steroids — in older adults (typically over 50).

The analysis draws primarily from the CDC/FDA Vaccine Adverse Event Reporting System (VAERS) data spanning 1990–2026. Researchers identified:

2,227 PMR cases reported after COVID-19 vaccination.

233 after influenza vaccination.

526 after all other vaccines combined.

To account for differences in reporting periods and vaccine exposure (COVID-19 vaccines available ~2020–2026 vs. longer for others), they calculated time-adjusted odds ratios (ORt):

Vs. influenza: 69.4 (95% CI: 51.4–93.6, p < 0.0001, Z = 27.7).

Vs. all other vaccines: 30.7 (95% CI: 23.1–40.8, p < 0.0001, Z = 23.6).

The headline's "6,800%" derives from the ~69-fold increase (69 × 100% ≈ 6,800% higher odds). Regulators consider a disproportionality signal ≥2 as noteworthy; these far exceed that, with high Z-scores suggesting very low chance occurrence.

The paper supplements this with a small case series of three patients:

1.A 51-year-old physician with severe PMR post-vaccination, spike antibody levels >21,000 U/mL.

2.A 65-year-old man with crippling pain after two Pfizer doses, needing prolonged steroids.

3.A 59-year-old physician developing PMR two weeks after a second dose, requiring years of treatment.

Proposed mechanisms include spike protein triggering autoimmunity via molecular mimicry, Toll-like receptor activation, Th17/IL-6 pathways, leading to vascular/muscle inflammation.

Hulscher/McCullough group portray PMR as often misattributed to "aging" or degenerative issues, potentially hiding vaccine links. They call for:

Greater clinical vigilance for post-vaccination musculoskeletal issues.

More research (e.g., spike protein detection in tissues).

Better monitoring of autoimmune complications.

The McCullough Foundation positions itself as leading vaccine safety efforts amid alleged government underfunding. They continue to do a fine job exposing the dangers of the COVID vax, which as time passes and the issue goes off the public "boil," need constant exposure.

https://www.thefocalpoints.com/p/breaking-study-covid-19-vaccination